Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare the blood pressure effects of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists with the blood pressure effects of glucagon-like peptide-1 (GLP-1) receptor agonists.
Authors
- Douglas M Salzwedel (ORCID: https://orcid.org/0000-0003-0115-862X)
- A. Gougeon (ORCID: https://orcid.org/0009-0009-6941-730X)
- Guillaume Grenet (ORCID: https://orcid.org/0000-0002-5237-2581)
- Ciprian D Jauca
- James M Wright
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- University of British Columbia (CA)
- Hospices Civils de Lyon (FR)
- Laboratoire de Biométrie et Biologie Evolutive (FR)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1002/14651858.cd016144
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29